Alector, Inc. (ALEC)
2.00
+0.02
(+1.01%)
USD |
NASDAQ |
Mar 06, 16:00
2.00
0.00 (0.00%)
After-Hours: 20:00
Alector EPS Diluted (Quarterly) : -0.3403 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vistagen Therapeutics, Inc. | -0.4475 |
| Ocugen, Inc. | -0.0567 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -37.27M |
| Revenue (Quarterly) | 6.237M |
| Total Expenses (Quarterly) | 43.50M |
| Enterprise Value | 0.9342M |
| Gross Profit Margin (Quarterly) | 63.78% |
| Profit Margin (Quarterly) | -597.5% |
| Earnings Yield | -69.48% |
| Normalized Earnings Yield | -66.95 |